1.
Taniwaki M, Yoshida M, Matsumoto Y, Shimura K, Kuroda J, Kaneko H. ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING. Mediterr J Hematol Infect Dis [Internet]. 2018Feb.15 [cited 2020May30];10(1):e2018014. Available from: https://mjhid.org/index.php/mjhid/article/view/2018.014